DCM Shriram Fine

Why is DCM Shriram Fine Chemicals Ltd falling/rising?

As of 30-Aug, DCM Shriram Fine Chemicals Ltd's stock price has risen to 27.28, reflecting a 1.04% increase. This rise is driven by strong relative performance, trading above key moving averages, increased investor participation, and adequate liquidity.

As of 30-Aug, DCM Shriram Fine Chemicals Ltd is experiencing a rise in its stock price, currently at 27.28, which reflects an increase of 0.28 or 1.04%. This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 1.11% today, indicating strong relative performance. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend in its price movement.<BR><BR>Moreover, there has been a significant increase in investor participation, with delivery volume on 27 August rising by 127.01% compared to the 5-day average. This surge in trading activity indicates growing interest among investors, which often correlates with price increases. Lastly, the stock's liquidity is adequate for trading, further supporting its price stability and potential for growth. Overall, these factors contribute to the current rise in DCM Shriram Fine Chemicals Ltd's stock price.

Which are the latest news on DCM Shriram Fine?

Should I buy, sell or hold DCM Shriram Fine Chemicals Ltd?

What does DCM Shriram Fine do?

DCM Shriram Fine Chemicals Ltd is a micro-cap company in the commodity chemicals industry, incorporated in 2021 as a subsidiary of DCM Shriram Industries. As of March 2026, it reported net sales of 93 Cr and a net loss of 4 Cr, with a market cap of INR 218 Cr.

Overview: <BR>DCM Shriram Fine Chemicals Ltd operates in the commodity chemicals industry and is classified as a micro-cap company.<BR><BR>History: <BR>The company was incorporated on September 29, 2021, and became a public limited company with a Certificate of Incorporation issued on September 30, 2021. Prior to this, it was a wholly owned subsidiary of DCM Shriram Industries Limited. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 93 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: -4 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 218 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 44 <BR>Dividend Yield: 1.60% <BR>Debt-Equity: -0.21 <BR>Return on Equity: -2.14% <BR>Price to Book: 1.09<BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the DCM Shriram Fine?

Peers of DCM Shriram Fine include Andhra Petrochem, National Perox., Alufluoride, Genus Prime, and others. Genus Prime has the highest 1-year return at 29.98%, while Kesar Petroprod. has the lowest at -51.00%.

Peers: The peers of DCM Shriram Fine are Andhra Petrochem, National Perox., Alufluoride, Genus Prime, Hind.Organ.Chem., ARCL Organics, IVP, Kesar Petroprod., ZR2 Bioenergy, Kanchi Karpooram.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride and ARCL Organics, while Average management risk is found at Andhra Petrochem, IVP, Kesar Petroprod., and Kanchi Karpooram, and the rest. Below Average management risk is noted at National Perox., Genus Prime, Hind.Organ.Chem., and ZR2 Bioenergy. Growth is Good at Alufluoride, Genus Prime, ARCL Organics, and Kesar Petroprod., while Below Average growth is seen at Andhra Petrochem, National Perox., Hind.Organ.Chem., IVP, ZR2 Bioenergy, and Kanchi Karpooram, and the rest. Good capital structure is present at National Perox., Alufluoride, ARCL Organics, and Kanchi Karpooram, while Average capital structure is noted at Andhra Petrochem and IVP, and Below Average at Genus Prime, Hind.Organ.Chem., Kesar Petroprod., and ZR2 Bioenergy.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Genus Prime at 29.98%, while Kesar Petroprod. has the lowest at -51.00%. DCM Shriram Fine's 1-year return is not available for comparison. Additionally, the peers with negative six-month returns include Kesar Petroprod., ZR2 Bioenergy, and ARCL Organics.

How big is DCM Shriram Fine?

As of 14th August, DCM Shriram Fine Chemicals Ltd has a market capitalization of 222.35 Cr and reported net sales of 400.02 Cr, with a net loss of 3.43 Cr in the latest four quarters. Shareholder's funds are 211.00 Cr, and total assets are valued at 295.40 Cr.

As of 14th August, DCM Shriram Fine Chemicals Ltd has a market capitalization of 222.35 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported net sales of 400.02 Cr. However, it experienced a loss of 3.43 Cr in net profit during the same period.<BR><BR>The latest annual reporting period shows that the company's shareholder's funds stand at 211.00 Cr, while total assets are valued at 295.40 Cr.

When is the next results date for DCM Shriram Fine Chemicals Ltd?

The next results date for DCM Shriram Fine Chemicals Ltd is 14 August 2026.

The next results date for DCM Shriram Fine Chemicals Ltd is scheduled for 14 August 2026.

Are DCM Shriram Fine Chemicals Ltd latest results good or bad?

DCM Shriram Fine Chemicals Ltd's latest results are concerning, showing a net loss of ₹3.83 crore in Q4 FY26, marking a 260.25% decline year-on-year. The company has faced three consecutive quarters of losses, negative operating margins, and a return on equity of -2.14%, indicating significant operational challenges and a negative outlook.

The latest results for DCM Shriram Fine Chemicals Ltd are concerning and indicate a significant decline in financial performance. In Q4 FY26, the company reported a net loss of ₹3.83 crore, which is a drastic drop of 260.25% year-on-year. This marks the third consecutive quarter of losses, with the losses widening compared to the previous quarter.<BR><BR>Operating margins have also deteriorated sharply, turning negative at -2.71%, down from a positive 6.78% in the same quarter last year. This reflects severe operational challenges, as the company is unable to cover its basic operating expenses from its core business activities. Additionally, net sales fell slightly by 0.29% year-on-year to ₹93.08 crore, but this decline masks deeper issues within the company's operations.<BR><BR>The return on equity has collapsed to -2.14%, indicating that the company is not generating returns for its shareholders. Overall, the financial performance suggests that DCM Shriram Fine Chemicals is facing an operational crisis, raising serious concerns about its viability moving forward. Given these results, the outlook appears quite negative.